Lynda Charters

X-linked retinoschisis is a congenital disorder that results in visual impairment in boys at an early age. No treatment is currently available, and surgical repair fails in many cases.

In a study, investigators found that no characteristics of inflammatory bowel disease are related to ocular manifestations of the disease.

Industry leaders will come together Dec. 16-17 in Marco Island, Florida, to present the latest data and treatments.

A novel regimen may represent an improvement over current methods of handling postsurgical pain in procedures that require corneal epithelial debridement, according to investigators.

Symptoms in the eye may not be substantial in patients with COVID-19.

Investigators discuss the evolution of innovative technology for the hearing impaired and how vision can play a role.

Several issues may restimulate the virus in those patients with prior exposure.

The Grail study finds the device can offer positive outcomes for patients.

While the surgeons reported that the BW filter provided higher contrast during nucleus and viscous removal and posterior capsular polishing, they subjectively reported no significant advantage of using a BW filter.

According to the company, new imaging options presenting opportunity for better outcomes for patients.

Janet B. Serle, MD, discusses the pros and cons of various treatment options.

Physicians use a new administration method to treat patients diagnosed with noninfectious uveitis.

Speaking at the American Society of Retina Specialists 2022 annual meeting at the Jacob K. Javits Convention Center in New York, J. Fernando Arevalo, MD, PhD, The Edmund F. and Virginia B. Ball Professor of Ophthalmology, chairman of ophthalmology at Johns Hopkins Bayview Medical Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, outlined his investigation of the anatomic and functional outcomes of pars plana vitrectomy, scleral buckle, or a combination of the 2, and suggested that the combination approach may need further consideration.

Speaking at the American Society of Retina Specialists 2022 annual meeting in New York, Carl Danzig, MD, detailed how treatment with faricimab in patients with neovascular AMD resulted in improvements in visual acuity, central subfield thickness and pigment epithelial detachments.

During a presentation at the American Society of Retina Specialists 2022 annual meeting in New York, Bobeck S. Modjtahedi, MD, presented results of a study that examined the accuracy of tools for predicting the risk of vision-threatening diabetic retinopathy.

In a presentation at the American Society of Retina Specialists, Dimitra Skondra, MD, PhD, points out that the low-to-moderate doses of metformin carried the greatest potential benefit in a retrospective case-control study.

In a presentation at the American Society of Retina Specialists 2022 annual meeting at the Jacob K. Javits Convention Center in New York, Yoshihiro Yonekawa, MD, detailed that primary scleral buckling achieved the best visual acuity, and pointed out that rhegmatogenous detachments increased with age.

According to William B. Trattler, MD, progression of the disease before cross-linking often can be identified over a period of months.

According to Mark Lobanoff, DO, earlier treatment also can mean the best possible results for patients.

The 40th annual scientific meeting of the American Society of Retina Specialists will be held July 13-16 at the Jacob K. Javits Convention Center in New York.

The procedure ensures the removal of cortical remnants, capsular fibrosis during cataract surgery.

Using a cloud-based digital health option can save time during surgery.

Ophthalmologists should look past the eyes in patients presenting with a persistent ocular allergic response and be mindful of accompanying nasal symptoms.

The lower energy applications and slower sweep speeds offer marked IOP reductions in patients.

Researchers believe this may be the first report of the use of topical brimonidine gel for the treatment of eyelid ptosis associated with cosmetic use of botulinum toxin.